CURAPATH
Live / Registered — Registered (as of 29 Apr 2025)
What this means for you
Registered since 29 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97534202
- Registration number
- 7779108
- Mark type
- Stylized text
- Filed
- 04 Aug 2022
- Published for opposition
- 02 Jan 2024
- Registered
- 29 Apr 2025
- Attorney of record
- Julie R. Fenstermaker
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations, namely, polyamino acid based therapeutics, polymer, and lipid based pharmaceutical preparations for the treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, genetic and immune system related diseases and disorders
- Class 040 — Treatment of materials: Custom manufacture of polyamino acid based and nanoparticle based biopharmaceutical preparations for purposes of scientific and medical research and for therapeutic purposes
- Class 042 — Scientific and technological services: Consulting services in the fields of biotechnology, pharmaceutical research and development of polyamino acid based and nanoparticle molecules for research, drug, vaccine, and therapeutic product use; product research and development for use in manufacturing of polyamino acid based and nanoparticle molecules; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biotechnology and polyamino acid based and nanoparticle molecules
- Class 045 — Legal and security services: Regulatory compliance consulting services in the biotechnology fields, namely, reviewing standards and practices and assisting third parties with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology
Owner
- Polypeptide Therapeutic Solutions USA LLC, San Francisco, CA, US
- Polypeptide Therapeutic Solutions USA LLC, San Francisco, CA, US
- Polypeptide Therapeutic Solutions USA LLC, San Francisco, CA, US
Prosecution history
- 29 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 07 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jan 2025 — USE AMENDMENT FILED
- 02 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2024 — SOU EXTENSION 1 GRANTED
- 23 Aug 2024 — SOU EXTENSION 1 FILED
- 23 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jan 2024 — PUBLISHED FOR OPPOSITION